Passive 13.56 MHz RFID tags complying with the ISO 18000-3 Mode 1 standard have been accepted by the International Society for Blood Transfusion and the U.S. Food and Drug Administration (FDA) as data carriers to augment ISBT128 bar-code data on blood products. This is the first FDA-permitted implementation of RFID in all phases of blood banking. In this session, learn about RFID technology and equipment selection, as well as FDA-required RF safety testing, integration with the blood enterprise-computing system, RFID tag performance and tag survivability issues. The presenter will also discuss the benefits and deployment issues at the BloodCenter of Wisconsin and the University of Iowa Health Center.
Speakers:
Alfonso Gutierrez, UW RFID Lab Director and Director, UWEBC Research and Education;
Clive P. Hohberger, Ph.D, RFID Systems Architect, BloodCenter of Wisconsin